## Adjuvant Management of Adenoid Cystic Carcinoma (ACC) ### Clinical Context Adenoic cystic carcinoma is an aggressive malignant salivary gland tumor characterized by: - Slow initial growth but rapid progression - High propensity for perineural invasion (hallmark feature) - Early lymph node and distant metastasis (lungs, bone) - Poor prognosis despite treatment ### Why Adjuvant Radiation ± Chemotherapy is Correct **Key Point:** Adenoid cystic carcinoma is an aggressive malignancy requiring multimodal therapy: surgery + adjuvant radiation ± chemotherapy. **High-Yield:** Adjuvant radiation therapy is the standard of care for ACC after surgical resection, particularly in the presence of: 1. Perineural invasion (present in this case) 2. Positive surgical margins 3. Advanced stage (T3/T4, nodal involvement) 4. Facial nerve involvement (as in this case) ### Radiation Protocol - **Dose:** 50–66 Gy in conventional fractionation (1.8–2 Gy/day) - **Timing:** Begins 4–6 weeks post-operatively - **Concurrent chemotherapy:** Often added for high-risk features (perineural invasion, positive margins, advanced stage) - **Cisplatin** is the preferred agent (weekly or every 3 weeks) - Improves locoregional control and overall survival ### Why Radiation is Essential | Feature | Rationale | |---------|----------| | Perineural invasion | Microscopic disease along nerve sheaths; radiation targets these areas | | Facial nerve involvement | Indicates aggressive disease; radiation improves local control | | High recurrence risk | Adjuvant RT reduces recurrence from ~60% to ~30% | | Chemotherapy role | Concurrent cisplatin improves survival in high-risk cases | **Clinical Pearl:** Adenoid cystic carcinoma has a propensity for late distant metastasis (especially to lungs) even after successful locoregional treatment. Long-term follow-up (5–10 years) is essential. **Mnemonic:** **PERINEURAL** = Perineural invasion is the hallmark of ACC; it mandates aggressive adjuvant therapy. ### Why Observation Alone is Inadequate ACC is an aggressive malignancy with: - 5-year recurrence rate of ~60% without adjuvant therapy - High risk of locoregional failure and distant metastasis - Observation is only appropriate for very early-stage (T1N0M0) ACC without perineural invasion — this case does NOT qualify. ### Why Chemotherapy Alone is Insufficient Chemotherapy without radiation: - Does not provide adequate locoregional control - Is not curative as monotherapy - Is reserved for metastatic or unresectable disease - Concurrent chemoradiation is superior to either modality alone [cite:Robbins 10e Ch 16; NCCN Head and Neck Cancer Guidelines 2023]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.